Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Fareed

Showing results (371-380 of 384) with videos related to

Pageof 39
Sort By:
Shock (Augusta, Ga.)|June 13, 1998
Low molecular weight heparin prevents the pulmonary hemodynamic and pathomorphologic effects of endotoxin in a porcine acute lung injury modelB J Darien, J Fareed, K S Centgraf, et al.
Biochimica Et Biophysica Acta|August 6, 1999
Structural features and anticoagulant activities of a novel natural low molecular weight heparin from the shrimp Penaeus brasiliensisC P Dietrich, J F Paiva, R A Castro, et al.
Atherosclerosis|March 12, 2010
Leukocyte telomere length is associated with measures of subclinical atherosclerosisA G Panayiotou, A N Nicolaides, M Griffin, et al.
International Angiology : a Journal of the International Union of Angiology|June 1, 1996
Deep venous thrombosis prophylaxis with low molecular weight heparin and elastic compression in patients having total hip replacement. A randomised controlled trialE P Kalodiki, D A Hoppensteadt, A N Nicolaides, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|November 8, 2001
Day-night variations in blood levels of nitric oxide, T-TFPI, and E-selectinE L Kanabrocki, M George, R C Hermida, et al.
JAMA|May 12, 2000
Circadian relationship of serum uric acid and nitric oxideE L Kanabrocki, J L Third, M D Ryan, et al.
Seminars in Thrombosis and Hemostasis|January 1, 1996
Plasma levels of the molecular markers of coagulation and fibrinolysis in patients with peripheral arterial diseaseA Strano, D Hoppensteadt, J M Walenga, et al.
The Journal of Invasive Cardiology|April 5, 2001
Enoxaparin and abciximab adjunctive pharmacotherapy during percutaneous coronary interventionD J Kereiakes, C Grines, E Fry, et al.
International Angiology : a Journal of the International Union of Angiology|June 12, 2014
Medical management of patients with peripheral arterial diseaseP Poredoš, M Jezovnik, E Kalodiki, et al.
Circulation|April 11, 2001
Argatroban anticoagulant therapy in patients with heparin-induced thrombocytopeniaB E Lewis, D E Wallis, S D Berkowitz, et al.
Pageof 39

Showing results (371-380 of 384) with videos related to

Sort By:
Pageof 39
Shock (Augusta, Ga.)|June 13, 1998
Low molecular weight heparin prevents the pulmonary hemodynamic and pathomorphologic effects of endotoxin in a porcine acute lung injury modelB J Darien, J Fareed, K S Centgraf, et al.
Biochimica Et Biophysica Acta|August 6, 1999
Structural features and anticoagulant activities of a novel natural low molecular weight heparin from the shrimp Penaeus brasiliensisC P Dietrich, J F Paiva, R A Castro, et al.
Atherosclerosis|March 12, 2010
Leukocyte telomere length is associated with measures of subclinical atherosclerosisA G Panayiotou, A N Nicolaides, M Griffin, et al.
International Angiology : a Journal of the International Union of Angiology|June 1, 1996
Deep venous thrombosis prophylaxis with low molecular weight heparin and elastic compression in patients having total hip replacement. A randomised controlled trialE P Kalodiki, D A Hoppensteadt, A N Nicolaides, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|November 8, 2001
Day-night variations in blood levels of nitric oxide, T-TFPI, and E-selectinE L Kanabrocki, M George, R C Hermida, et al.
JAMA|May 12, 2000
Circadian relationship of serum uric acid and nitric oxideE L Kanabrocki, J L Third, M D Ryan, et al.
Seminars in Thrombosis and Hemostasis|January 1, 1996
Plasma levels of the molecular markers of coagulation and fibrinolysis in patients with peripheral arterial diseaseA Strano, D Hoppensteadt, J M Walenga, et al.
The Journal of Invasive Cardiology|April 5, 2001
Enoxaparin and abciximab adjunctive pharmacotherapy during percutaneous coronary interventionD J Kereiakes, C Grines, E Fry, et al.
International Angiology : a Journal of the International Union of Angiology|June 12, 2014
Medical management of patients with peripheral arterial diseaseP Poredoš, M Jezovnik, E Kalodiki, et al.
Circulation|April 11, 2001
Argatroban anticoagulant therapy in patients with heparin-induced thrombocytopeniaB E Lewis, D E Wallis, S D Berkowitz, et al.
Pageof 39